Showing results (71-80 of 123) with videos related to
Sort By:
Pageof 13
Hinyokika Kiyo. Acta Urologica Japonica|May 1, 1996
[Bilateral renal cell carcinoma with extension into the vena cava associated with von Hippel-Lindau disease: a case report and review of the literature]M Minamide, H Nakatsu, S Isaka, et al.The Journal of Biological Chemistry|July 25, 2000
Syk is required for the activation of Akt survival pathway in B cells exposed to oxidative stressJ Ding, T Takano, S Gao, et al.European Journal of Biochemistry|September 1, 1994
Translocation, activation and association of protein-tyrosine kinase (p72syk) with phosphatidylinositol 3-kinase are early events during platelet activationS Yanagi, K Sada, Y Tohyama, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 23, 2006
Significance of human beta-defensins in the epithelial lining fluid of patients with chronic lower respiratory tract infectionsS Yanagi, J Ashitani, K Imai, et al.Cancer Letters|July 1, 1987
Promotion of hepatocarcinogenesis by suxibuzone in rats initiated with 3'-methyl-4-dimethylaminoazobenzeneS Yanagi, M Sakamoto, S Takahashi, et al.Plos Biology|July 11, 2024
Mutations in nucleotide metabolism genes bypass proteasome defects in png-1/NGLY1-deficient Caenorhabditis elegansKatherine S Yanagi, Briar Jochim, Sheikh Omar Kunjo, et al.Journal of Biochemistry|July 1, 1995
Syk and Lyn are involved in radiation-induced signaling, but inactivation of Syk or Lyn alone is not sufficient to prevent radiation-induced apoptosisC Yang, S Maruyama, S Yanagi, et al.International Journal of Andrology|June 1, 1986
Changes in the volume and histology of retractile testes in prepubertal boysH Ito, Z Kataumi, S Yanagi, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2000
Protein-tyrosine kinase Syk expressed in human nasal fibroblasts and its effect on RANTES productionT Yamada, S Fujieda, S Yanagi, et al.Journal of the National Cancer Institute|August 1, 1985
Enhancement of hepatocarcinogenesis by sorbitan fatty acid ester, a liver pyruvate kinase activity-reducing substanceS Yanagi, M Sakamoto, S Takahashi, et al.Pageof 13